Latest total current liabilities for RMED: $20M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Catheter Precision (RMED) currently reports a total current liabilities of $20M as of March 2026. That compares with $4.1M in the prior-year period — up 382.7% year over year. Use the charts on this page to explore Catheter Precision's total current liabilities history and peer comparisons.
Catheter Precision's total current liabilities increased from $4.1M to $20M — a 382.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Catheter Precision reported $20M in total current liabilities as of March 2026. That compares with $4.1M in the prior-year period — up 382.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Catheter Precision, and consider following RMED for alerts when major investors trade the stock.
Catheter Precision is classified in the Healthcare sector. On total current liabilities, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RMED with unrelated industries.